News

2017 Oct 05

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

NEW YORK (October 5, 2017) — Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s... Read more

2017 Oct 05

MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards

Two of the 2017 Prostate Cancer Foundation (PCF) Challenge Awards were awarded to teams including Meyer Cancer Center investigators. Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation ($1 million): Scott... Read more

2017 Oct 02

American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,

American Society of Hematology (ASH) announced the names of five investigators whose research has been awarded $150,000 through the ASH Bridge Grant Program. Meyer Cancer Center member Selina Chen-Kiang, Ph.D. was one of the... Read more

2017 Sep 27

The Differences Between Right- and Left-Sided Tumors in Colon Cancer

Video of The Differences Between Right- and Left-Sided Tumors in Colon Cancer Manish A. Shah, M.D., discusses the differences between right- and left-sided colon cancer. Read more

2017 Sep 21

How A Liquid Biopsy Changes Cancer Treatment

David Nanus, M.D., and Scott Tagawa, M.D., M.S., speak to Fox 5 News about liquid biopsies in cancer treatment. Read more

2017 Sep 21

Metastatic Breast Cancer Affects Bone Mineral Before Spreading

This article by Tom Fleischman first appeared in the Cornell Chronicle . When breast cancer metastasizes, or spreads, one of its most likely destinations is bone. In fact, four in five metastatic breast cancer patients will... Read more

2017 Sep 19

Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit

A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more

2017 Sep 18

Epigenetic Code Plays a Role in Acute Myeloid Leukemia

This article by Bridget Kuehn first appeared in the Cornell Chronicle . Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment... Read more

2017 Sep 15

Olivier Elemento, PhD, Appointed Director of the Englander Institute for Precision Medicine

Dr. Olivier Elemento , a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill... Read more

2017 Sep 15

Double Targeting Ligands to Identify and Treat Prostate Cancer

John Babich, PhD, and collaborators have demonstrated a new way to identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the featured basic article of the September... Read more

Neuroendocrine prostate cancer cells from a patient biopsy. Image credit: Dr. Loredana Puca

2017 Sep 07

Weill Cornell Medicine Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research

NEW YORK (September 7, 2017) — Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI), part of the National... Read more

prostate cancer neuroendocrine spore rubin beltran NEPC

2017 Sep 07

Meyer Cancer Center Investigators Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research

The Weill Cornell Medicine Specialized Programs of Research Excellence (SPORE) in Prostate Cancer, led by Mark Rubin, M.D., has been funded by the National Cancer Institute (NCI). Read more

2017 Aug 31

The most important lesson I learned from a patient: Optimism Leads to Achievement

Brendon Stiles, M.D., reflects on his experience with an inspiring young patient. Read more

2017 Aug 30

Impact of the FDA Approval of CTL019 in ALL

Gail J. Roboz, M.D., discusses the impact of the FDA approval of tisagenlecleucel (CTL019; Kymriah) in select pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). Read more

2017 Aug 30

Drug may curb female infertility from cancer treatments

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a study by Ithaca member John Schimenti, Ph.D. Read more

2017 Aug 29

The next steps for biopsies in prostate cancer

Jim Hu, M.D., MPH, discusses the next steps of biopsies for patients with prostate cancer. Read more

2017 Aug 28

Retinoids’ Extraordinary Potential

Feature about Lorraine Gudas, Ph.D., who is studying the role of Vitamin A and retinoic acid in cancer and other diseases. Read more

2017 Aug 25

Symposium addresses role of truth in universities, society

Holly Prigerson, Ph.D., spoke about the role of truth in their fields and in society during an academic symposium to celebrate the inauguration of Cornell's 14th president, Martha E. Pollack. Read more

2017 Aug 25

Immunotherapy gains traction as potential malignant pleural mesothelioma treatment

Ashish Saxena, M.D., Ph.D., comments on the results of a study on the use of immunotherapy to treat patients with the lung cancer mesothelioma. Read more

2017 Aug 25

Evolving paradigms in AML treatment

Gail Roboz, M.D., discusses evolving paradigms in treatment of patients with acute myeloid leukemia (AML). Read more

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards

American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,

The Differences Between Right- and Left-Sided Tumors in Colon Cancer

How A Liquid Biopsy Changes Cancer Treatment

Metastatic Breast Cancer Affects Bone Mineral Before Spreading

Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit

Epigenetic Code Plays a Role in Acute Myeloid Leukemia

Olivier Elemento, PhD, Appointed Director of the Englander Institute for Precision Medicine

Double Targeting Ligands to Identify and Treat Prostate Cancer

Weill Cornell Medicine Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research

Meyer Cancer Center Investigators Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research

The most important lesson I learned from a patient: Optimism Leads to Achievement

Impact of the FDA Approval of CTL019 in ALL

Drug may curb female infertility from cancer treatments

The next steps for biopsies in prostate cancer

Retinoids’ Extraordinary Potential

Symposium addresses role of truth in universities, society

Immunotherapy gains traction as potential malignant pleural mesothelioma treatment

Evolving paradigms in AML treatment

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters